The European acamprosate trials: conclusions for research and therapy.

Lesch, O M; Riegler, A; Gutierrez, K; Hertling, I; Ramskogler, K; Semler, B; Zoghlami, A; Benda, N; Walter, H

Lesch, O M; Riegler, A; Gutierrez, K; Hertling, I; Ramskogler, K; Semler, B; Zoghlami, A; Benda, N; Walter, H.

Affiliation

Lesch OM; Department of Psychiatry, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Otto.M.Lesch@akh-wien.ac.at

J Biomed Sci ; 8(1): 89-95, 2001.

Article in En | MEDLINE | ID: mdl-11173981

Subject(s)

Alcoholism/drug therapy; Taurine/analogs & derivatives; Taurine/therapeutic use; Acamprosate; Alcohol Deterrents/standards; Alcohol Deterrents/therapeutic use; Alcoholism/classification; Alcoholism/therapy; Clinical Trials as Topic; Databases, Factual; Dopamine Antagonists/pharmacology; Dopamine Antagonists/therapeutic use; Europe; Secondary Prevention; Taurine/standards; United States

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Database: MEDLINE Main subject: Taurine / Alcoholism Type of study: Clinical_trials / Observational_studies Country/Region as subject: America do norte / Europa Language: En Journal: J Biomed Sci Year: 2001 Document type: Article

Search on Google

XML

PubMed Links